Clinical Trial: A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia

Brief Summary: Multicenter, multinational study to collect consistent baseline growth measurements on pediatric patients with Achondroplasia being considered for subsequent enrollment in Study 111-202. No study drug is administered.

Detailed Summary:
Sponsor: BioMarin Pharmaceutical

Current Primary Outcome: Collection of consistent growth measurements [ Time Frame: Assessed every 3 months for up to 60 months ]

Patients will be screened and undergo a series of growth measurements on Day 1 and every 3 months thereafter. No study drug is administered.


Original Primary Outcome: Collection of consistent growth measurements [ Time Frame: Assessed every 3 months for up to 36 months ]

Patients will be screened and undergo a series of growth measurements on Day 1 and every 3 months thereafter. No study drug is administered.


Current Secondary Outcome:

Original Secondary Outcome:

Information By: BioMarin Pharmaceutical

Dates:
Date Received: May 11, 2012
Date Started: April 2012
Date Completion: November 2017
Last Updated: April 26, 2016
Last Verified: April 2016